1. Home
  2. CTM vs ICCC Comparison

CTM vs ICCC Comparison

Compare CTM & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTM

Castellum Inc.

HOLD

Current Price

$0.66

Market Cap

63.1M

Sector

Technology

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$8.39

Market Cap

64.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTM
ICCC
Founded
2019
1982
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.1M
64.0M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
CTM
ICCC
Price
$0.66
$8.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
622.6K
28.1K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
83.33
53.85
EPS
N/A
N/A
Revenue
$52,866,001.00
$26,493,169.00
Revenue This Year
$20.36
N/A
Revenue Next Year
$6.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.10
51.64
52 Week Low
$0.48
$4.52
52 Week High
$1.56
$9.08

Technical Indicators

Market Signals
Indicator
CTM
ICCC
Relative Strength Index (RSI) 43.87 61.70
Support Level $0.63 $5.78
Resistance Level $0.76 N/A
Average True Range (ATR) 0.04 0.29
MACD 0.00 0.00
Stochastic Oscillator 25.27 50.00

Price Performance

Historical Comparison
CTM
ICCC

About CTM Castellum Inc.

Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: